Kazia Therapeutics (KZIA) Other Accumulated Expenses (2021)

Kazia Therapeutics' Other Accumulated Expenses history runs 1 years deep, the most recent figure standing at $3.1 million for Q4 2021.

• Quarterly Other Accumulated Expenses changed N/A year-over-year to $3.1 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $3.1 million (changed N/A YoY) and the FY2021 annual result came in at $2.3 million, changed N/A from the prior year.
• Other Accumulated Expenses was $3.1 million for Q4 2021 at Kazia Therapeutics, up from $2.3 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $3.1 million in Q4 2021 and bottomed at $2.3 million in Q2 2021.